Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine in clinical practice and the issues involved

被引：0
|
作者：
Bradshaw, H. [1 ]
机构：
[1] Singleton Hosp, Swansea, W Glam, Wales
来源：
HIV MEDICINE | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P114
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Therapeutic drug monitoring of tenofovir disoproxil and emtricitabine in oral HIV pre-exposure prophylaxis (PrEP) users who have undergone gastrointestinal surgery
    Ismail, Muhammad Azam
    Tittle, Victoria
    Jones, Rachael
    Loftus, Hannah
    Girometti, Nicolo
    Dosekun, Olamide
    Stegmann, Katrina
    Pool, Erica
    Tariq, Shema
    Nakamura, Anna
    Tyler, Stephanie
    Coleman, Harry
    Teh, Yee Suh
    Boffito, Marta
    INTERNATIONAL JOURNAL OF STD & AIDS, 2025, 36 (03) : 250 - 254
  • [22] The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B (vol 71, pg 281, 2016)
    Solomon, M.
    Schechter, M.
    Liu, A. Y.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (03) : E82 - E82
  • [23] Pre-exposure Prophylaxis (PrEP) in Clinical Settings: Are Medical Providers PrEPared?
    Wilder, Terri
    Harris, Naomi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 293 - 293
  • [24] HIV Pre-exposure Prophylaxis (PrEP): A Survey of Dermatologists' Knowledge and Practice Patterns
    Gutierrez, Daniel
    Shah, Payal
    Zampella, John G.
    CUTIS, 2022, 110 (04):
  • [25] On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know
    Saberi, Parya
    Scott, Hyman M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (04) : 1285 - 1288
  • [26] Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men
    Anderson, Peter L.
    Glidden, David V.
    Liu, Albert
    Buchbinder, Susan
    Lama, Javier R.
    Vicente Guanira, Juan
    McMahan, Vanessa
    Bushman, Lane R.
    Casapia, Martin
    Montoya-Herrera, Orlando
    Veloso, Valdilea G.
    Mayer, Kenneth H.
    Chariyalertsak, Suwat
    Schechter, Mauro
    Bekker, Linda-Gail
    Kallas, Esper Georges
    Grant, Robert M.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (151)
  • [27] Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
    Plosker, Greg L.
    DRUGS, 2013, 73 (03) : 279 - 291
  • [28] Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre-exposure prophylaxis
    Bonnichsen, Mark H.
    Tschuchnigg, Mark
    Post, Jeffrey J.
    Bye, William
    INTERNAL MEDICINE JOURNAL, 2022, 52 (06) : 1099 - 1100
  • [29] Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
    Greg L. Plosker
    Drugs, 2013, 73 : 279 - 291
  • [30] Observed adherence-concentration benchmarks for emtricitabine/tenofovir alafenamide pre-exposure prophylaxis for African women
    Mugwanya, K.
    Mugo, N.
    Saina, M.
    Brown, C.
    Akelo, N.
    Schaafsma, T.
    Rechkina, E.
    Ngure, K.
    Mbugua, S.
    Hill, E.
    Chohan, B.
    Gichuru, E.
    Nzuve, P.
    Wu, L.
    Morrison, S.
    Rooney, J.
    Bushman, L.
    Anderson, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27
12345